Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katja, Arve"'
Autor:
Outi Närvänen, Mikko Hippeläinen, Esko Alhava, Katja Arve, Juha Rutanen, Tiina T. Tuomisto, Seppo Ylä-Herttuala, Mikko Hiltunen, Tuomas T. Rissanen, Hannu Manninen, Ismo Vajanto, Heikki T. Räsänen
Publikováno v:
The Journal of Gene Medicine. 4:371-380
Background Recent studies have suggested the therapeutic potential of vascular endothelial growth factor (VEGF) gene therapy in ischemic skeletal muscle. However, only limited information is available about the effects of VEGF gene therapy in differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70d46b5b0c1dd64b8cae03df06164bac
https://doi.org/10.1002/jgm.287
https://doi.org/10.1002/jgm.287
Autor:
Pia Leppänen, Juha Rutanen, Mikko I. Kettunen, Mikko P. Turunen, Ismo Vajanto, Johanna E. Markkanen, Mari Niemi, Tuomas T. Rissanen, Katja Arve, Mikko Hiltunen, Esko Alhava, Risto A. Kauppinen, Seppo Ylä-Herttuala
Publikováno v:
The American Journal of Pathology. 160:1393-1403
Vascular endothelial growth factor (VEGF) is a hypoxia-inducible endothelial cell mitogen and survival factor. Its receptor VEGFR-2 (KDR/Flk-1) mediates these effects. We studied the expression of VEGF and VEGFR-2 in ischemic human and rabbit skeleta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb5e9800cd1acc4a964b9186cdff324
https://doi.org/10.1016/s0002-9440(10)62566-7
https://doi.org/10.1016/s0002-9440(10)62566-7
Autor:
Outi Närvänen, Mikko I. Kettunen, Johanna E. Markkanen, Tuomas T. Rissanen, Linda Cashion, Ismo Vajanto, Gabor M. Rubanyi, Pekka Taipale, Seppo Ylä-Herttuala, Katja Arve, Risto A. Kauppinen, Marcin Gruchała, Suvi Jauhiainen, Juha Rutanen
Publikováno v:
The FASEB Journal. 17:100-102
Previous studies have shown that fibroblast growth factor (FGF)-1, FGF-2, and FGF-5 induce therapeutic angiogenesis. Here, we investigated the potential of FGF-4 for therapeutic neovascularization in comparison to vascular endothelial growth factor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e89f5306fb0d02e051e28453495fc92
https://doi.org/10.1096/fj.02-0377fje
https://doi.org/10.1096/fj.02-0377fje
Autor:
Ismo, Vajanto, Tuomas T, Rissanen, Juha, Rutanen, Mikko O, Hiltunen, Tiina T, Tuomisto, Katja, Arve, Outi, Närvänen, Hannu, Manninen, Heikki, Räsänen, Mikko, Hippeläinen, Esko, Alhava, Seppo, Ylä-Herttuala
Publikováno v:
The journal of gene medicine. 4(4)
Recent studies have suggested the therapeutic potential of vascular endothelial growth factor (VEGF) gene therapy in ischemic skeletal muscle. However, only limited information is available about the effects of VEGF gene therapy in different regions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d01feeaed38a226d79f7f8b8395dd5c0
https://pubmed.ncbi.nlm.nih.gov/12124979
https://pubmed.ncbi.nlm.nih.gov/12124979